BioSpecifics Technologies and Auxilium Pharmaceuticals announced the availability of Xiaflex (collagenase clostridium histolyticum) for the treatment of adult Dupuytren’s contracture patients with a palpable cord. Physicians may access Xiaflex only after they have enrolled and received training through the Xiaflex Xperience managed distribution program.

Xiaflex is available as a 0.9mg single-use vial.

For more information call (877) XIAFLEX or visit www.xiaflex.com.